F. David Alcraft


As Chairman of Bridgehead International, a market access consultancy acquired by GfK and subsequently IPSOS, David has spent the last two decades championing an effective dialogue between industry and payers. He is concerned that innovations should find their right place in the diagnosis and treatment of patients and that benefits from research are fully realised. 

"I am using my experience to establish, with my colleagues, an efficient platform for product pricing to ensure timely access for patients.”